دورية أكاديمية

Abnormal mechanosensing and cofilin activation promote the progression of ascending aortic aneurysms in mice.

التفاصيل البيبلوغرافية
العنوان: Abnormal mechanosensing and cofilin activation promote the progression of ascending aortic aneurysms in mice.
المؤلفون: Yamashiro Y; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Papke CL; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Kim J; Department of Mechanical Engineering and Materials Science, Washington University, St. Louis, MO 63130, USA., Ringuette LJ; Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec H3A 0C7, Canada., Zhang QJ; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Liu ZP; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Mirzaei H; Department of Biochemistry and Proteomics Core Unit, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Wagenseil JE; Department of Mechanical Engineering and Materials Science, Washington University, St. Louis, MO 63130, USA., Davis EC; Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec H3A 0C7, Canada., Yanagisawa H; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Life Science Center of Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba 305-8577, Japan. hkyanagisawa@tara.tsukuba.ac.jp.
المصدر: Science signaling [Sci Signal] 2015 Oct 20; Vol. 8 (399), pp. ra105. Date of Electronic Publication: 2015 Oct 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, D.C. : American Association for the Advancement of Science
مواضيع طبية MeSH: Actin Depolymerizing Factors/*physiology , Aortic Aneurysm/*physiopathology, Animals ; Disease Progression ; Mice
مستخلص: Smooth muscle cells (SMCs) and the extracellular matrix (ECM) are intimately associated in the aortic wall. Fbln4(SMKO) mice with an SMC-specific deletion of the Fbln4 gene, which encodes the vascular ECM component fibulin-4, develop ascending aortic aneurysms that have increased abundance of angiotensin-converting enzyme (ACE); inhibiting angiotensin II signaling within the first month of life prevents aneurysm development. We used comparative proteomics analysis of Fbln4(SMKO) aortas from postnatal day (P) 1 to P30 mice to identify key molecules involved in aneurysm initiation and expansion. At P14, the actin depolymerizing factor cofilin was dephosphorylated and thus activated, and at P7, the abundance of slingshot-1 (SSH1) phosphatase, an activator of cofilin, was increased, leading to actin cytoskeletal remodeling. Also, by P7, biomechanical changes and underdeveloped elastic lamina-SMC connections were evident, and the abundance of early growth response 1 (Egr1), a mechanosensitive transcription factor that stimulates ACE expression, was increased, which was before the increases in ACE abundance and cofilin activation. Postnatal deletion of Fbln4 in SMCs at P7 prevented cofilin activation and aneurysm formation, suggesting that these processes required disruption of elastic lamina-SMC connections. Phosphoinositide 3-kinase (PI3K) is involved in the angiotensin II-mediated activation of SSH1, and administration of PI3K inhibitors from P7 to P30 decreased SSH1 abundance and prevented aneurysms. These results suggest that aneurysm formation arises from abnormal mechanosensing of SMCs resulting from the loss of elastic lamina-SMC connections and from increased SSH1 and cofilin activity, which may be potential therapeutic targets for treating ascending aortic aneurysms.
(Copyright © 2015, American Association for the Advancement of Science.)
References: Proc Natl Acad Sci U S A. 1975 Apr;72(4):1314-6. (PMID: 1055406)
J Cell Sci. 1994 Mar;107 ( Pt 3):727-36. (PMID: 8006086)
Hum Mol Genet. 1995;4 Spec No:1799-809. (PMID: 8541880)
Am J Med Genet A. 2007 Nov 15;143A(22):2635-41. (PMID: 17937443)
Circ Res. 2015 Apr 10;116(8):1448-61. (PMID: 25858068)
Annu Rev Genomics Hum Genet. 2008;9:283-302. (PMID: 18544034)
Auton Neurosci. 2001 Dec 10;94(1-2):34-41. (PMID: 11775705)
Proc Natl Acad Sci U S A. 2012 Sep 18;109 (38):E2523-32. (PMID: 22927399)
N Engl J Med. 2006 Aug 24;355(8):788-98. (PMID: 16928994)
Nature. 2013 Nov 7;503(7474):126-30. (PMID: 24107997)
N Engl J Med. 2014 Nov 27;371(22):2061-71. (PMID: 25405392)
Int Immunopharmacol. 2005 Mar;5(3):495-502. (PMID: 15683846)
J Cell Biol. 2011 Nov 28;195(5):721-7. (PMID: 22123860)
Bioinformatics. 2010 Apr 15;26(8):1131-2. (PMID: 20189941)
Science. 2007 Jun 22;316(5832):1749-52. (PMID: 17588931)
Cancer Sci. 2009 Apr;100(4):770-7. (PMID: 19469020)
Sci Signal. 2013 Dec 17;6(306):ra108. (PMID: 24345679)
Am J Physiol. 1996 Jun;270(6 Pt 2):H2100-7. (PMID: 8764262)
Circ Res. 2012 May 25;110(11):1411-22. (PMID: 22511748)
Nature. 2002 Jan 10;415(6868):168-71. (PMID: 11805834)
J Clin Invest. 2001 Nov;108(9):1387-95. (PMID: 11696584)
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7142-7. (PMID: 11997476)
Nat Cell Biol. 2005 Jan;7(1):21-9. (PMID: 15580268)
Gene. 2008 Sep 15;421(1-2):81-8. (PMID: 18577431)
Biochem Biophys Res Commun. 2010 Aug 27;399(3):365-72. (PMID: 20659422)
Cell Signal. 2013 Feb;25(2):457-69. (PMID: 23153585)
Nat Cell Biol. 2009 May;11(5):545-56. (PMID: 19329994)
Cell. 2002 Jan 25;108(2):233-46. (PMID: 11832213)
Lab Invest. 1993 Jan;68(1):89-99. (PMID: 8423679)
J Proteome Res. 2012 Dec 7;11(12):6282-90. (PMID: 23088505)
Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H221-9. (PMID: 21536846)
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2424-31. (PMID: 21868701)
Am J Hum Genet. 2013 Aug 8;93(2):398-404. (PMID: 23910461)
Circ Res. 1999 Apr 2;84(6):678-87. (PMID: 10189355)
Nat Genet. 2007 Dec;39(12):1488-93. (PMID: 17994018)
Science. 2011 Apr 15;332(6027):358-61. (PMID: 21493862)
J Biol Chem. 2014 Sep 19;289(38):26302-13. (PMID: 25100728)
Mol Biol Cell. 2009 Jun;20(11):2650-60. (PMID: 19339277)
Nat Rev Mol Cell Biol. 2013 Jul;14(7):405-15. (PMID: 23778968)
Nature. 2011 Jul 20;475(7356):316-23. (PMID: 21776077)
J Biol Chem. 2004 Dec 31;279(53):55675-81. (PMID: 15492009)
Circ Res. 2008 Feb 29;102(4):432-8. (PMID: 18096821)
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2172-9. (PMID: 23868934)
J Biol Chem. 2005 Apr 1;280(13):12683-9. (PMID: 15671020)
Nat Genet. 2006 Mar;38(3):343-9. (PMID: 16444274)
Sci Transl Med. 2013 May 1;5(183):183ra58, 1-11. (PMID: 23636094)
Cancer Res. 2009 Jul 15;69(14):5634-8. (PMID: 19567672)
J Biol Chem. 2008 Nov 21;283(47):32542-52. (PMID: 18809681)
Eur J Hum Genet. 2010 Aug;18(8):895-901. (PMID: 20389311)
Nat Genet. 2012 Nov;44(11):1249-54. (PMID: 23023332)
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19029-34. (PMID: 19855011)
J Vis Exp. 2010 Apr 21;(38):null. (PMID: 20410870)
Cardiovasc Res. 2010 Dec 1;88(3):520-9. (PMID: 20628007)
Genesis. 2009 Jan;47(1):14-8. (PMID: 18942088)
Curr Opin Cell Biol. 2011 Oct;23(5):569-78. (PMID: 21807492)
J Clin Invest. 2014 Mar;124(3):1329-39. (PMID: 24531548)
Genes Cells. 1996 Jan;1(1):73-86. (PMID: 9078368)
Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H257-64. (PMID: 20495146)
Annu Rev Cell Dev Biol. 1999;15:185-230. (PMID: 10611961)
Curr Opin Cell Biol. 1996 Feb;8(1):66-73. (PMID: 8791404)
Circ Res. 2010 Feb 19;106(3):583-92. (PMID: 20019329)
J Biol Chem. 2004 Feb 20;279(8):7193-8. (PMID: 14645219)
EMBO Rep. 2011 Jun;12(6):527-33. (PMID: 21525957)
معلومات مُعتمدة: R01 HL105314 United States HL NHLBI NIH HHS; R01 HL106305 United States HL NHLBI NIH HHS; R01HL106305 United States HL NHLBI NIH HHS; R01 HL115560 United States HL NHLBI NIH HHS; R01 HL085749 United States HL NHLBI NIH HHS; T32 HL007360 United States HL NHLBI NIH HHS; F32 HL122076-01 United States HL NHLBI NIH HHS; 5T32HL007360-34 United States HL NHLBI NIH HHS; F32 HL122076 United States HL NHLBI NIH HHS; R01HL115560 United States HL NHLBI NIH HHS
المشرفين على المادة: 0 (Actin Depolymerizing Factors)
تواريخ الأحداث: Date Created: 20151022 Date Completed: 20160801 Latest Revision: 20181113
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC5572214
DOI: 10.1126/scisignal.aab3141
PMID: 26486174
قاعدة البيانات: MEDLINE
الوصف
تدمد:1937-9145
DOI:10.1126/scisignal.aab3141